ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.201,58
-0,19%
Brent Oil
79,395
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. ETFs
  4. Reino Unido
  5. LSE
  6. Ls 2x Salesforc (CRME)

  7. Ls 2x Salesforc (CRME) Notícias

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:CRME
DataHoraFonteTítuloCódigoCompanhia
24/04/202311:47UK RegulatoryLeverage Shares PLC Issuer Call Redemption ConfirmationLSE:CRMELs 2x Salesforc
21/12/200920:05PR Newswire (US)Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase PlansLSE:CRME
17/12/200921:00PR Newswire (US)Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator StudyLSE:CRME
09/11/200911:40PR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
06/11/200921:00PR Newswire (US)Cardiome to Release Third Quarter ResultsLSE:CRME
02/11/200917:35PR Newswire (US)Cardiome To Present At Oppenheimer Healthcare ConferenceLSE:CRME
28/10/200918:58PR Newswire (US)Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 TrialLSE:CRME
16/10/200921:54PR Newswire (US)Cardiome Pharma Corp. Announces Final Results of Tender OfferLSE:CRME
14/10/200907:00PR Newswire (US)Cardiome Pharma Corp. Announces Preliminary Results of Tender OfferLSE:CRME
01/09/200915:57PR Newswire (US)Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender OfferLSE:CRME
28/08/200914:30PR Newswire (US)Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of LSE:CRME
25/08/200918:11PR Newswire (US)Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common SharesLSE:CRME
11/08/200908:45PR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
10/08/200920:45PR Newswire (US)Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol AgreementLSE:CRME
10/08/200917:35PR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
03/08/200918:16PR Newswire (US)Cardiome Announces Management TransitionLSE:CRME
28/07/200912:45PR Newswire (US)Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.LSE:CRME
19/05/200909:30PR Newswire (US)Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now EffectiveLSE:CRME
15/05/200917:05PR Newswire (US)Cardiome Reports First Quarter ResultsLSE:CRME
28/11/200820:31PR Newswire (US)Cardiome Discloses Chairman And CEO's Involuntary Share SaleLSE:CRME
24/10/200800:40PR Newswire (US)Cardiome Announces Filing Of Shelf Registration StatementLSE:CRME
09/10/200813:20PR Newswire (US)Cardiome Provides Regulatory UpdateLSE:CRME
11/08/200817:30PR Newswire (US)Cardiome to Release Second Quarter Results and Hold Conference CallLSE:CRME
11/08/200810:18PR Newswire (US)Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)LSE:CRME
23/07/200815:10PR Newswire (US)Cardiome Announces Preferred Share FinancingLSE:CRME
14/07/200809:25PR Newswire (US)Cardiome Announces Positive Phase 2b Results For Oral VernakalantLSE:CRME
13/07/200813:00PR Newswire (US)Cardiome To Hold Conference CallLSE:CRME
03/06/200806:32PR Newswire (US)K I L L K I L L K I L L -- Cardiome Pharma Corp.LSE:CRME
28/05/200817:25PR Newswire (US)TEST - Jay 14 - Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as StrategicLSE:CRME
12/05/200818:45PR Newswire (US)Cardiome To Release 2008 First Quarter ResultsLSE:CRME
 Apresentando as notícias mais relevantes sobre:LSE:CRME

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
SGPS3
SPRINGS ON
BOV
SAPR4
SANEPAR PN
BOV
RPMG3
PET MANGUINH ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados